T 0957/18 (Synergistic anti-CD47 therapy/LELAND STANFORD JUNIOR UNIVERSITY) of 24.09.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T095718.20200924
- Date of decision
- 24 September 2020
- Case number
- T 0957/18
- Petition for review of
- -
- Application number
- 10817793.2
- IPC class
- A61K 39/00C07K 16/28C12P 21/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Synergistic anti-CD47 therapy for hematologic cancers
- Applicant name
- The Board of Trustees of the Leland Stanford
Junior University - Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent with the claim of the main request, filed during the oral proceedings of 24 September 2020, and a description to be adapted thereto.